TrialCancer medicine2019

A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma.

Brian A Van Tine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.